![]() | Bio Synq DAO (BIOS)ICO Upcoming Token sale: Jun 10, 2025 – Jun 13, 2025Bio Synq DAO builds a decentralized research ecosystem where scientists, funders and communities co-create and co-own intellectual property- setting a new standard for transparency, global collaboration, and open biomedical innovations. IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice. |
Overview
|
What is Bio Synq DAO
Built on the principles of Decentralized Science (DeSci), we are a community-governed ecosystem leveraging blockchain technology, smart contracts, and decentralized governance to dismantle barriers in biotech innovation.
Our mission is to democratize access to resources, tools, and collaboration, enabling researchers, citizen scientists, and biohackers worldwide to co-create solutions with unprecedented speed, transparency, and inclusivity.
BIO SYNQ DAO addresses the systemic challenges in biomedical research by leveraging decentralization, collaboration, and transparency. The platform empowers researchers through a decentralized ecosystem that fosters global collaboration, eliminates centralized control, and facilitates shared decisionmaking.
BIO SYNQ tokenizes intellectual property, ensuring fair ownership and royalty distribution while reducing traditional patent system costs.
AI-powered tools enhance research by identifying high-potential projects, validating data, and improving reproducibility.
With cross-chain funding mechanisms, BIO SYNQ democratizes access to financial support and enables participation from multiple blockchain ecosystems. The tokenization of real-world assets allows researchers to leverage critical infrastructure without significant upfront costs.
Through these innovative solutions, BIO SYNQ DAO transforms biomedical research, accelerating breakthroughs and creating a sustainable ecosystem that rewards collaboration and innovation.
DetailsPublic sales: Jun 10, 2025 - Jun 13, 2025Token supply: 1,125,000,000 BIOS Total tokens for sale: 56,250,000 BIOS Soft cap: 10,000 USD Hard cap: 2,000,000 USD LegalRegistration country: IndonesiaRegistration year: 2025 | Token infoTicker: BIOSType: Utility-token Token distribution: Seed Sale - 5% Early Community Sale - 10% Public Sale - 20% Team - 7.5% Advisors - 2.5% Treasury - 20% Ecosystem - 15% Liquidity Pool - 20% |
Bio Synq DAO Roadmap
Objective: Establish the technical and governance bedrock for decentralized biotech collaboration.
- Core Initiatives:
- Launch cross-chain IP tokenization protocols for frictionless intellectual property exchange.
- Implement DeReview – a decentralized peer-review system enhanced by AI-driven validation.
- Develop interoperable funding rails to unify liquidity across blockchain networks.
- Success Metrics:
- Achieve $5B+ ecosystem valuation through standardized onchain workflows.
- Onboard 500+ research institutions to decentralized collaboration tools.
Objective: Bridge decentralized science with real-world biopharma innovation.
- Core Initiatives:
- Incubate breakthrough therapeutic verticals (e.g.,neurodegenerative diseases, gene editing).
- Pioneer IP-NFT frameworks for tokenizing lab infrastructure and clinical trial data.
- Transition 20% of conventional research pipelines to on-chain governance models.
- Success Metrics:
- Cultivate first DeSci unicorn ($10B+ valuation) within BIO SYNQ’s accelerator network.
- Secure regulatory recognition for asset tokenization in major markets.
Objective: Become humanity’s primary engine for solving existential challenges.
- Core Initiatives:
- Crowdsolve grand scientific challenges (e.g., Alzheimer’s cures, pandemic resilience).
- Establish decentralized R&D infrastructure across developing nations.
- Transition majority of academic funding to communitygoverned mechanisms.
- Success Metrics:
- Reduce therapeutic development costs by 90% compared to legacy systems.
- Engage 1M+ citizen scientists in collaborative discovery processes.
Project team




